ALIBETEZIN

ສ່ວນປະກອບ
Dapagliflozin…………………………………..10mg
ຂໍ້ບົ່ງໃຊ້

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • Indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.
  • Chronic Kidney Disease: Indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.
  • Heart Failure: indicated to reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent heart failure visit in adults with HF.

ຂະໜາດບັນຈຸ:

  • 7 tablets/blister, 2 blisters/box.
  • 7 tablets/blister, 50 blisters/box.

ເລກທະບຽນ: 08 L 1177/24
Download ALIBETEZIN Drug Registration Certificate

ໝວດໝູ່,
FacebookXPinterestWhatsappEmailShortlink

Brand name: ALIBETEZIN

ສ່ວນປະກອບ:
ໃນ 1 ເມັດປະກອບດ້ວຍ:
Dapagliflozin……………………..10mg

ຂໍ້ບົ່ງໃຊ້:

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • Indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.
  • Chronic Kidney Disease: Indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.
  • Heart Failure: indicated to reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent heart failure visit in adults with HF.

ວິທີໃຊ້:

  • Blood glucose control: Oral administration. It is recommended to take it in the morning, with a starting dose of 5mg each time, once a day. According to blood sugar levels, the dosage can be increased to 10mg per dose, once a day.
  • Heart failure or: Take 10mg orally once a day.
  • Chronic kidney disease: 10mg orally once a day.

ຂໍ້ຫ້າມໃຊ້:

  • History of serious hypersensitivity reaction to the product.
  • Contraindicated in dialysis patients.

ຄຳເຕືອນ:

  • This product is not applicable to type I diabetes or type I diabetes ketoacidosis.
  • Dapagliflozin can cause osmotic diuresis, which may lead to reduced blood volume.
  • In combination with sulfonylureas or insulin may cause hypoglycemia.
  • Genital fungal infection.
  • Pay attention to perineal necrotizing fasciitis.
  • Pregnant and lactating women should use with caution.
  • Use with caution for children.

ຜົນຂ້າງຄຽງ:
Renal impairment, female genital fungal infections, nasopharyngitis, and urinary tract infections.

ຮູບແບບ: ຢາເມັດສີເຫຼືອງ.

ວັນທີໝົດອາຍຸ: 24 ເດືອນ ຫຼັງຈາກວັນທີຜະລິດ.

ຂະໜາດບັນຈຸ:

  • 7 tablets/blister, 2 blisters/box.
  • 7 tablets/blister, 50 blisters/box.

ການເກັບຮັກສາ:

  • ເກັບຮັກສາໄວ້ໃນກັບກ່ອງ ບັນຈຸເດີມ, ບໍ່ໃຫ້ຖືກແສງ ເກັບໄວ້ໃນຫ້ອງທີ່ມີ ອຸນຫະພູມ ລະຫວ່າງ 20℃-25℃.
  • ເກັບໄວ້ໃຫ້ຫ່າງໄກຈາກມືເດັກນ້ອຍ.

ຂໍ້ຄວາມປະຕິເສດຄວາມຮັບຜິດຊອບ

ຂໍ້ມູນເທິງເວັບໄຊນີ້ກ່ຽວກັບຢາຂອງເຮົາແມ່ນມີຈຸດປະສົງເພື່ອການສຶກສາທົ່ວໄປເເທົ່ານັ້ນ ແລະ ບໍ່ຄວນຖືເປັນການແນະນຳທາງການແພດ, ການວິນິດໄສ ຫຼື ການປິ່ນປົວຈາກແພດຜູ້ຊ່ຽວຊານ. ຢ່າເບິ່ງຂ້າມຕໍ່ຄຳແນະນຳຂອງແພດຜູ້ຊ່ຽວຊານ ຫຼື ຊັກຊ້າໃນການເຂົ້າຮັບການຮັກສາ ຍ້ອນສິ່ງທີ່ໄດ້ອ່ານຈາກເວັບໄຊນີ້.

ເພື່ອຄວາມປອດໄພຂອງທ່ານ:

ຫ້າມວິນິດໄສຕົນເອງ ຫຼື ຮັກສາອາການໃດໆ ໂດຍອາໄສຂໍ້ມູນເທິງເວັບໄຊນີ້ພຽງຢ່າງດຽວ. ຖ້າຫາກທ່ານມີຄຳຖາມ ຫຼື ຂໍ້ກັງວົນກ່ຽວກັບຢາ ກະລຸນາ

ຜະລິດຕະພັນທີ່ກ່ຽວຂ້ອງ